Maternal, Fetal Considerations for the Treatment and Management of Lymphoma During Pregnancy
Although 1 in 1000 lymphoma diagnoses occurs in pregnancy, literature on best practices for treatment in this patient group is limited.
Lymphoma
LYMPHOMA ADVISOR
FEATURED CONTENT
-
-
New Analysis of the Tumor Microenvironment Reveals 3 Subtypes in Large B-Cell Lymphoma of the Brain
The signaling pathways detected may shed light on new treatment strategies. -
Hepatosplenic T-cell Lymphoma: Recent Progress and Future Considerations
Researchers reviewed the clinical/pathologic aspects of HSTCL and summarized the latest molecular studies and potential novel therapeutic targets. -
Targeted Therapy for Non-Hodgkin Lymphoma: Current Progress and Future Plans
Novel immunotherapies and small molecule pathway inhibitors are transforming the standard of care for some of the most challenging lymphoma subtypes. -
Expert Q&A: Understanding the Oncogenic Role of HIV in Burkitt Lymphoma
While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady.
VIDEO SERIES
LYMPHOMA NEWS
Promising, Early Results for Combined HDAC and mTOR Inhibition in Relapsed/Refractory Hodgkin Lymphoma
Keytruda Approval Expands Classical Hodgkin Lymphoma Indication
Brentuximab Vedotin Plus Nivolumab as Chemotherapy-Free Strategy for Hodgkin Lymphoma in Older Patients
Pregnant Patients With Non-Hodgkin Lymphoma May Receive Chemotherapy
Obinutuzumab With Cytarabine Induction for Transplant-Eligible Mantle Cell Lymphoma
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Lymphoma
